Mark E. Johnson
Impact in
- Pharmaceutical Science top 1%
- Advancements in Transdermal Drug Delivery
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advancements in Transdermal Drug Delivery 3
-
- RNA Interference and Gene Delivery 6
- Lipid Membrane Structure and Behavior 3
- Co-authors
- Daniel Blankschtein (4 shared papers)Róbert Langer (4 shared papers)Samir Mitragotri (2 shared papers)Zhibin Guan (6 shared papers)Nathan J. Oldenhuis (4 shared papers)Ashish B. Patel (1 shared paper)Hanxiang Zeng (2 shared papers)Olga Cañadas (2 shared papers)
- Journals
- Journal of Pharmaceutical Sciences (3 papers)Biophysical Journal (2 papers)Beilstein Journal of Organic Chemistry (1 paper)Biomacromolecules (1 paper)Bioconjugate Chemistry (1 paper)
- Partner nations
- United StatesSpainDenmark
In The Last Decade
Mark E. Johnson
14 papers receiving 791 citations
Peers
Comparison fields: 5 of 65
- Pharmaceutical Science 428
- Biomaterials 56
- Dermatology 27
- Computational Theory and Mathematics 54
- Molecular Biology 190
Countries citing papers authored by Mark E. Johnson
This map shows the geographic impact of Mark E. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Johnson more than expected).
Fields of papers citing papers by Mark E. Johnson
This network shows the impact of papers produced by Mark E. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Johnson. The network helps show where Mark E. Johnson may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 278 | |
| 2 | 1996 | 112 | |
| 3 | 1995 | 89 | |
| 4 | 1999 | 75 | |
| 5 | 2015 | 63 | |
| 6 | 2016 | 45 | |
| 7 | 2006 | 41 | |
| 8 | 2003 | 32 | |
| 9 | 2018 | 29 | |
| 10 | 2006 | 27 | |
| 11 | 2001 | 17 | |
| 12 | 2016 | 15 | |
| 13 | 2015 | 9 | |
| 14 | 2016 | 9 | |
| 15 | 2008 | 0 |
About Mark E. Johnson
Mark E. Johnson is a scholar working on Pharmaceutical Science, Molecular Biology, Information Systems and Management, Pulmonary and Respiratory Medicine and Safety, Risk, Reliability and Quality, having authored 15 papers that have together received 841 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (6 papers), Advancements in Transdermal Drug Delivery (3 papers), Lipid Membrane Structure and Behavior (3 papers), Neonatal Respiratory Health Research (2 papers), Tuberculosis Research and Epidemiology (1 paper), Biotechnology and Related Fields (1 paper), Immunotherapy and Immune Responses (1 paper) and Dendrimers and Hyperbranched Polymers (1 paper). The work is most often cited by research in Pharmaceutical Science (428 citations), Biomaterials (56 citations), Dermatology (27 citations), Computational Theory and Mathematics (54 citations) and Molecular Biology (190 citations). Mark E. Johnson has collaborated with scholars based in United States, Spain and Denmark. Frequent co-authors include Daniel Blankschtein, Róbert Langer, Samir Mitragotri, Zhibin Guan, Nathan J. Oldenhuis, Ashish B. Patel, Hanxiang Zeng, Olga Cañadas, Timothy N. Tiambeng and Cristina Casals. Their work appears in journals such as Journal of Pharmaceutical Sciences, Biophysical Journal, Beilstein Journal of Organic Chemistry, Biomacromolecules and Bioconjugate Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.